SCHEMBL1670170

SCHEMBL1670170

CN(C)C=C(Br)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1670167 1.00
SCHEMBL15260093 1.00
Bromide SCHEMBL5420538 0.97
SCHEMBL20326800 0.73 TSHR (0.31)
SCHEMBL24934021 0.71
SCHEMBL19266821 0.71
Dimethylformamide SCHEMBL28155853 0.69
SCHEMBL359274 0.69
SCHEMBL9249509 0.67
SCHEMBL9249500 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-20170260178-A1 ANTIBACTERIAL COMPOUNDS SPERO GYRASE INC (US) 2017-09-14 US disclosed
EP-2828257-B1 ANTIBACTERIAL COMPOUNDS BIOTA EUROPE LTD (GB) 2017-07-26 EP disclosed
US-9604976-B2 Antibacterial compounds SPERO GYRASE, INC. (US) 2017-03-28 US disclosed
US-20150329530-A1 ANTIBACTERIAL COMPUNDS SPERO GYRASE, INC. 2015-11-19 US disclosed
US-9056858-B2 Indazole and pyrazolopyridine compounds as CCR1 receptor antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-06-16 US disclosed
EP-2828257-A1 ANTIBACTERIAL COMPOUNDS Biota Europe Ltd (GB) 2015-01-28 EP disclosed
US-8906902-B2 Antibacterial compounds BIOTA EUROPE LIMITED (GB) 2014-12-09 US disclosed
EP-2178375-B1 PYRAZOLOÝ1,5-A¨PYRIMIDINE DERIVATIVES MERCK SHARP & DOHME (US) 2014-09-24 EP disclosed
EP-2491028-B1 INDAZOLE AND PYRAZOLOPYRIDINE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2013-12-11 EP disclosed
EP-2178375-A1 PYRAZOLOÝ1,5-A¨PYRIMIDINE DERIVATIVES Merck Sharp & Dohme Corp. (US) 2010-04-28 EP disclosed
US-7534799-B2 Pyridomorphinans, thienomorphinans and use thereof SOUTHERN RESEARCH INSTITUTE (US) 2009-05-19 US disclosed
WO-2009014620-A1 PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES MERCK & CO., INC. (US) 2009-01-29 WO disclosed
US-20060264452-A1 Pyridomorphinans, thienomorphinans and use thereof SOUTHERN RESEARCH INSTITUTE (US) 2006-11-23 US disclosed
US-7105675-B2 Pyridomorphinans, thienomorphinans and use thereof SOUTHERN RESEARCH INSTITUTE (US) 2006-09-12 US disclosed
US-7015326-B1 Pyridomorphinans, thienomorphinans and use thereof SOUTHERN RESEARCH INSTITUTE (US) 2006-03-21 US disclosed
US-20060047119-A1 Pyridomorphinans, thienomorphinans and use thereof SOUTHERN RESEARCH INSTITUTE (US) 2006-03-02 US disclosed
EP-1210084-A4 PYRIDOMORPHINANS, THIENOMOPRHINANS AND USE THEREOF SOUTHERN RES INST (US) 2002-11-13 EP disclosed
EP-1210084-A1 PYRIDOMORPHINANS, THIENOMOPRHINANS AND USE THEREOF Southern Research Institute (US) 2002-06-05 EP disclosed
WO-2001012197-A1 PYRIDOMORPHINANS, THIENOMOPRHINANS AND USE THEREOF SOUTHERN RESEARCH INSTITUTE (US) 2001-02-22 WO disclosed